|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/395 | |||
| A61P 35/00 | |||
| A61K 31/00 |
| (11) | Number of the document | 2205318 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08841724.1 |
| Date of filing the European patent application | 2008-10-22 | |
| (97) | Date of publication of the European application | 2010-07-14 |
| (45) | Date of publication and mention of the grant of the patent | 2014-11-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2008/008919 |
| Date | 2008-10-22 |
| (87) | Number | WO 2009/053038 |
| Date | 2009-04-30 |
| (30) | Number | Date | Country code |
| 07020820 | 2007-10-24 | EP |
| (72) |
FERTIG, Georg, DE
FRIESS, Thomas, DE
KLEIN, Christian, CH
UMANA, Pablo, CH
|
| (73) |
Roche Glycart AG,
Wagistrasse 18, 8952 Schlieren-Zuerich,
CH
|
| (54) | COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A PROTEASOME INHIBITOR |
| COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A PROTEASOME INHIBITOR |